Stocks Comparison
Solventum vs Stryker: revenue, profit, margins and growth compared
Solventum brought in $8.3B of revenue in fiscal 2025, Stryker $25.1B in fiscal 2025. Revenue changed by +0.9% at Solventum and +11.2% at Stryker on the year before, so Stryker grew faster. Solventum kept 18.7% of its revenue as net profit, Stryker 12.9%. Free cash flow was -$10M at Solventum and $4.3B at Stryker.
Side by side, latest fiscal year
| SOLV | SYK | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $8.3B | $25.1B |
| Revenue growth | +0.9% | +11.2% |
| Net income | $1.6B | $3.2B |
| Net margin | 18.7% | 12.9% |
| Free cash flow | -$10M | $4.3B |
| Free cash flow margin | -0.1% | 17.1% |
| Earnings per share (diluted) | $8.88 | $8.40 |
| Cash | $878M | $4B |
| Debt | $5B | $14.9B |
| Price to earnings | 10.1 | 32.4 |
| Market value | $15.2B | $104.5B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #49 of 523 · Health care | #24 of 523 · Health care |
Over the years
Questions about Solventum and Stryker
Which is bigger by revenue, Solventum or Stryker?
Stryker is bigger by revenue: $25.1B in fiscal 2025, against $8.3B for Solventum in fiscal 2025.
Which keeps more of its revenue as profit, Solventum or Stryker?
Solventum had a net margin of 18.7% in fiscal 2025; Stryker had 12.9% in fiscal 2025.
Which grew revenue faster, Solventum or Stryker?
In their latest fiscal years revenue changed by +0.9% at Solventum and +11.2% at Stryker.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.